Xtant Medical

Xtant Medical Announces Second Quarter 2018 Financial Results

BELGRADE, MT, Aug. 07, 2018 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a leader in the development of regenerative medicine products and medical devices, today reported financial and operating results for the second quarter ended June 30, 2018. Summary of Second Quarter 2018 Financial Highlights and Recent Announcements: Revenue for the second quarter of 2018 was $18.7 million, down from $21.4 million for the second quarter of 2017 Gross Margin for the second quarter of 2018 was 66.6%, compared to 63.2% for the same period in the prior year Net loss incurred in the second quarter 2018 was $5.0 million compared to a loss of $9.7 million in the same …